Advertisement
Loading...

Orpea SA

ORPEFPNK
Healthcare
Medical - Care Facilities
$14.22
$0.00(0.00%)
U.S. Market opens in 42h 14m
Advertisement

Orpea SA Fundamental Analysis

Orpea SA (ORPEF) shows weak financial fundamentals with a PE ratio of -6.60, profit margin of -5.06%, and ROE of -19.91%. The company generates $5.9B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.67%
PEG Ratio-0.40

Areas of Concern

ROE-19.91%
Operating Margin2.93%
Current Ratio0.64
We analyze ORPEF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -22.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-22.1/100

We analyze ORPEF's fundamental strength across five key dimensions:

Efficiency Score

Weak

ORPEF struggles to generate sufficient returns from assets.

ROA > 10%
-2.36%

Valuation Score

Excellent

ORPEF trades at attractive valuation levels.

PE < 25
-6.60
PEG Ratio < 2
-0.40

Growth Score

Moderate

ORPEF shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

ORPEF carries high financial risk with limited liquidity.

Debt/Equity < 1
6.11
Current Ratio > 1
0.64

Profitability Score

Weak

ORPEF struggles to sustain strong margins.

ROE > 15%
-1991.02%
Net Margin ≥ 15%
-5.06%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ORPEF Expensive or Cheap?

P/E Ratio

ORPEF trades at -6.60 times earnings. This suggests potential undervaluation.

-6.60

PEG Ratio

When adjusting for growth, ORPEF's PEG of -0.40 indicates potential undervaluation.

-0.40

Price to Book

The market values Orpea SA at 1.40 times its book value. This may indicate undervaluation.

1.40

EV/EBITDA

Enterprise value stands at -7.89 times EBITDA. This is generally considered low.

-7.89

How Well Does ORPEF Make Money?

Net Profit Margin

For every $100 in sales, Orpea SA keeps $-5.06 as profit after all expenses.

-5.06%

Operating Margin

Core operations generate 2.93 in profit for every $100 in revenue, before interest and taxes.

2.93%

ROE

Management delivers $-19.91 in profit for every $100 of shareholder equity.

-19.91%

ROA

Orpea SA generates $-2.36 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.36%

Following the Money - Real Cash Generation

Operating Cash Flow

Orpea SA generates limited operating cash flow of $502.25M, signaling weaker underlying cash strength.

$502.25M

Free Cash Flow

Orpea SA produces free cash flow of $305.04M, offering steady but limited capital for shareholder returns and expansion.

$305.04M

FCF Per Share

Each share generates $1.90 in free cash annually.

$1.90

FCF Yield

ORPEF converts 15.63% of its market value into free cash.

15.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.60

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.40

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.40

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.33

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

6.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.20

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.02

vs 25 benchmark

How ORPEF Stacks Against Its Sector Peers

MetricORPEF ValueSector AveragePerformance
P/E Ratio-6.6029.38 Better (Cheaper)
ROE-19.91%739.00% Weak
Net Margin-5.06%-53619.00% (disorted) Weak
Debt/Equity6.110.39 Weak (High Leverage)
Current Ratio0.644.03 Weak Liquidity
ROA-2.36%-20116.00% (disorted) Weak

ORPEF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Orpea SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ